Roivant Sciences Ltd.

• Roivant Sciences Ltd. Estimates – NASDAQ:ROIV
  TradingView · 23 Oct 2026
• Roivant Sciences Ltd Stock Price Live, Charts & News
  The Economic Times · 23 Oct 2026
• Roivant Sciences (ROIV) Jumps 6.2% to $37.10
  AlphaStreet · 21 Oct 2026
• Roivant, continuing ascent, claims another victory for rare disease drug
  BioPharma Dive · 21 Oct 2026
• Roivant Sciences stock surges on positive uveitis trial data
  Investing.com · 21 Oct 2026
• Form 8K Roivant Sciences Ltd. For: 21 October By Investing.com
  Investing.com India · 21 Oct 2026
• Form 8K Roivant Sciences Ltd. For: 21 October By Investing.com
  Investing.com UK · 21 Oct 2026
• Form 144 Roivant Sciences Ltd. For: 20 October By Investing.com
  Investing.com India · 20 Oct 2026
• Roivant Sciences (NDQ:ROIV): The Company Founded By Vivek Ramaswamy Is Trying To Industrialise Biotech Company Creation, But Is This a Better Approach?
  Stocks Down Under · 20 Oct 2026
• Roivant Sciences added to Citi's 90-day catalyst watch
  TradingView · 13 Oct 2026
• Form 4 Roivant Sciences Ltd.: Eric Venker (President & Immunovant CEO) For: 30 September
  Investing.com India · 13 Oct 2026
• Roivant, the ‘inveterate drug hunters’, enters commercial era with Lisraya
  BioSpace · 05 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →